Heart Transplant Failure and Rejection

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
PCI and implantation drug eluting stent or bare metal stentN/A1 trial
Active Trials
NCT03538509UnknownEst. Oct 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Verona PharmaPCI and implantation drug eluting stent or bare metal stent

Clinical Trials (1)

NCT03538509Verona PharmaPCI and implantation drug eluting stent or bare metal stent

Percutaneous Coronary Intervention in Patients witH OrthotoPic hEart Transplantation: the PCI-HOPE a Multicenter Study.

Start: Jan 2000Est. completion: Oct 2018
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space